eHealth (NASDAQ:EHTH – Get Rating) was downgraded by Citigroup from a “buy” rating to a “neutral” rating in a report released on Monday, Briefing.com reports. They presently have a $15.00 price target on the financial services provider’s stock, down from their previous price target of $37.00. Citigroup’s target price would indicate a potential upside of 13.29% from the stock’s previous close.
Other equities research analysts also recently issued research reports about the stock. Barclays downgraded shares of eHealth from an “overweight” rating to an “equal weight” rating and set a $22.00 target price for the company. in a research report on Tuesday, January 18th. Truist Financial cut shares of eHealth from a “buy” rating to a “hold” rating and set a $15.00 price target on the stock. in a research note on Wednesday, March 2nd. Deutsche Bank Aktiengesellschaft dropped their price target on shares of eHealth from $86.00 to $19.00 and set a “hold” rating on the stock in a research note on Monday, November 29th. Zacks Investment Research cut shares of eHealth from a “hold” rating to a “sell” rating in a research note on Wednesday, March 9th. Finally, Craig Hallum dropped their price target on shares of eHealth from $33.00 to $15.00 in a research note on Wednesday, March 2nd. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $35.60.
Shares of EHTH opened at $13.24 on Monday. The company has a market capitalization of $354.49 million, a P/E ratio of -2.89 and a beta of 0.13. The firm has a 50 day moving average of $17.11 and a 200 day moving average of $27.80. eHealth has a twelve month low of $9.59 and a twelve month high of $78.00.
eHealth (NASDAQ:EHTH – Get Rating) last announced its quarterly earnings results on Tuesday, March 1st. The financial services provider reported $0.25 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.62 by ($0.37). The firm had revenue of $243.51 million for the quarter, compared to the consensus estimate of $251.76 million. eHealth had a negative net margin of 19.39% and a negative return on equity of 7.99%. eHealth’s revenue was down 17.0% on a year-over-year basis. During the same period last year, the business earned $2.21 EPS. As a group, equities analysts predict that eHealth will post -2.88 earnings per share for the current fiscal year.
In other eHealth news, insider Phillip A. Morelock sold 7,000 shares of the business’s stock in a transaction on Friday, March 4th. The shares were sold at an average price of $11.75, for a total value of $82,250.00. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 5.00% of the stock is owned by insiders.
Institutional investors have recently bought and sold shares of the company. BNP Paribas Arbitrage SA increased its holdings in shares of eHealth by 116.2% in the 3rd quarter. BNP Paribas Arbitrage SA now owns 33,512 shares of the financial services provider’s stock worth $1,357,000 after buying an additional 18,015 shares during the last quarter. Centiva Capital LP bought a new position in eHealth during the 3rd quarter valued at about $204,000. Segall Bryant & Hamill LLC grew its holdings in eHealth by 70.7% during the 3rd quarter. Segall Bryant & Hamill LLC now owns 563,588 shares of the financial services provider’s stock valued at $22,825,000 after purchasing an additional 233,451 shares during the last quarter. Metropolitan Life Insurance Co NY grew its holdings in eHealth by 84,725.0% during the 2nd quarter. Metropolitan Life Insurance Co NY now owns 6,786 shares of the financial services provider’s stock valued at $396,000 after purchasing an additional 6,778 shares during the last quarter. Finally, Maverick Capital Ltd. bought a new position in eHealth during the 3rd quarter valued at about $9,096,000. Hedge funds and other institutional investors own 91.83% of the company’s stock.
eHealth Company Profile (Get Rating)
eHealth, Inc engages in the provision of Internet-based health insurance agency services for individuals, families, and small businesses. It operates through the following segments: Medicare and Individual, Family, and Small Business. The Medicare segment consists primarily of commissions earned from sale of Medicare-related health insurance plans.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Should you invest $1,000 in eHealth right now?
Before you consider eHealth, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and eHealth wasn’t on the list.
While eHealth currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The 5 Stocks Here